
In a historic move, Medicare has initiated negotiations with pharmaceutical companies to lower prices for high-cost prescription drugs. This effort, authorized by the Inflation Reduction Act, targets medications that have been on the market for several years without generic competition. The goal is to make essential drugs more affordable for beneficiaries, with the first negotiated prices expected to take effect in 2026. Medicare Drug Price Negotiations: All You Need to Know





Add comment